Gemciglan 1gm Injection
Marketer
Gland Pharma Limited
Salt Composition
Gemcitabine (1gm)
Overview Gemciglan 1gm Injection
Gemcitabine 1g injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is via injection by a healthcare professional, with dosage and frequency determined by your doctor based on your condition and potentially adjusted over time. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose may cause severe adverse reactions. Therapeutic benefits might not be apparent immediately; continue treatment unless instructed otherwise. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can suppress blood cell production, increasing infection risk, necessitating regular blood tests monitoring blood cell counts, along with cardiac, hepatic, and uric acid levels. Inform your doctor of pre-existing heart, liver, or kidney conditions, and all other medications (including anti-infectives), as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is crucial throughout treatment.
Primary Ingredients of Gemciglan 1gm Injection
The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.
Uses of Gemciglan 1gm Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemciglan 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gemciglan 1gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemciglan 1gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Gemciglan 1gm Injection works:
Gemcitabine 1g injection disrupts cancer cell DNA and RNA synthesis by replacing essential components. This halts further cellular growth and proliferation.
SAFETY ADVICE
AlcoholUNSAFE
Administering Gemciglan 1gm Injection concurrently with alcohol can result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemciglan 1gm Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Gemciglan 1gm Injection while breastfeeding poses a significant risk. Evidence indicates potential harm to the infant from the medication.
DrivingUNSAFE
Administering Gemciglan 1gm Injection might induce drowsiness, blurred vision, or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemciglan 1gm Injection's use in individuals with renal impairment. Physician consultation is recommended. Pre-treatment kidney function assessment is advisable, along with ongoing monitoring post-administration.
LiverCONSULT YOUR DOCTOR
Data regarding Gemciglan 1gm Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Gemciglan 1gm Injection :
NA
Facts to Know About Gemciglan 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Cytosine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently